Additionally, given the important role of both Pyk2 and FAK in microglia-supported glioma progression and dispersal, this study justifies the use of combined Pyk2/FAK blockers, which may have greater clinical relevance than specific Pyk2 or FAK inhibitors alone. Here, PTK2B is linked to glioma.